IL-17RC
Use this icon in our BioRender software along with 1000s of others. Create your next scientific figure in minutes!
SIGN UP FREE[{"image":"https://icons.biorender.com/w75xh75/5fe1ff5f76b8e7002833385e/il-17rc-02.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5fe1ff5f76b8e7002833385e/il-17rc-02.png"},{"image":"https://icons.biorender.com/w75xh75/5fe1ff5f76b8e7002833385d/il-17rc-02.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5fe1ff5f76b8e7002833385d/il-17rc-02.png"},{"image":"https://icons.biorender.com/w75xh75/5fe1ff5f76b8e7002833385c/il-17rc-02.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5fe1ff5f76b8e7002833385c/il-17rc-02.png"},{"image":"https://icons.biorender.com/w75xh75/5fe1ff5f76b8e7002833385b/il-17rc-02.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5fe1ff5f76b8e7002833385b/il-17rc-02.png"},{"image":"https://icons.biorender.com/w75xh75/5fe1ff5f76b8e7002833385a/il-17rc-02.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5fe1ff5f76b8e7002833385a/il-17rc-02.png"},{"image":"https://icons.biorender.com/w75xh75/5fe1ff5f76b8e70028333859/il-17rc-02.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5fe1ff5f76b8e70028333859/il-17rc-02.png"},{"image":"https://icons.biorender.com/w75xh75/5fe1ff5f76b8e70028333858/il-17rc-02.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5fe1ff5f76b8e70028333858/il-17rc-02.png"},{"image":"https://icons.biorender.com/w75xh75/5fe1ff5f76b8e70028333857/il-17rc-02.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5fe1ff5f76b8e70028333857/il-17rc-02.png"},{"image":"https://icons.biorender.com/w75xh75/5fe1ff5f76b8e70028333856/il-17rc-02.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5fe1ff5f76b8e70028333856/il-17rc-02.png"},{"image":"https://icons.biorender.com/w75xh75/5fe1ff5f76b8e70028333855/il-17rc-02.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5fe1ff5f76b8e70028333855/il-17rc-02.png"},{"image":"https://icons.biorender.com/w75xh75/5fe1ff5f76b8e70028333854/il-17rc-02.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5fe1ff5f76b8e70028333854/il-17rc-02.png"},{"image":"https://icons.biorender.com/w75xh75/5fe1ff5f76b8e70028333853/il-17rc-02.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5fe1ff5f76b8e70028333853/il-17rc-02.png"},{"image":"https://icons.biorender.com/w75xh75/5fe1ff5f76b8e70028333852/il-17rc-02.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5fe1ff5f76b8e70028333852/il-17rc-02.png"},{"image":"https://icons.biorender.com/w75xh75/5fe1ff5f76b8e70028333851/il-17rc-02.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5fe1ff5f76b8e70028333851/il-17rc-02.png"},{"image":"https://icons.biorender.com/w75xh75/5fe1ff5f76b8e70028333850/il-17rc-02.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5fe1ff5f76b8e70028333850/il-17rc-02.png"},{"image":"https://icons.biorender.com/w75xh75/5fe1ff5f76b8e7002833384f/il-17rc-02.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5fe1ff5f76b8e7002833384f/il-17rc-02.png"},{"image":"https://icons.biorender.com/w75xh75/5fe1ff5f76b8e7002833384e/il-17rc-02.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5fe1ff5f76b8e7002833384e/il-17rc-02.png"},{"image":"https://icons.biorender.com/w75xh75/5fe1ff5f76b8e7002833384d/il-17rc-02.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5fe1ff5f76b8e7002833384d/il-17rc-02.png"},{"image":"https://icons.biorender.com/w75xh75/5fe1ff5f76b8e7002833384c/il-17rc-02.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5fe1ff5f76b8e7002833384c/il-17rc-02.png"},{"image":"https://icons.biorender.com/w75xh75/5fe1ff5f76b8e7002833384b/il-17rc-02.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5fe1ff5f76b8e7002833384b/il-17rc-02.png"},{"image":"https://icons.biorender.com/w75xh75/5fe1ff5f76b8e7002833384a/il-17rc-02.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5fe1ff5f76b8e7002833384a/il-17rc-02.png"},{"image":"https://icons.biorender.com/w75xh75/5fe1ff5f76b8e70028333849/il-17rc-02.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5fe1ff5f76b8e70028333849/il-17rc-02.png"},{"image":"https://icons.biorender.com/w75xh75/5fe1ff5f76b8e70028333848/il-17rc-02.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5fe1ff5f76b8e70028333848/il-17rc-02.png"},{"image":"https://icons.biorender.com/w75xh75/5fe1ff5f76b8e70028333847/il-17rc-02.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5fe1ff5f76b8e70028333847/il-17rc-02.png"},{"image":"https://icons.biorender.com/w75xh75/5fe1ff5f76b8e70028333846/il-17rc-02.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5fe1ff5f76b8e70028333846/il-17rc-02.png"},{"image":"https://icons.biorender.com/w75xh75/5fe1ff5f76b8e70028333845/il-17rc-02.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5fe1ff5f76b8e70028333845/il-17rc-02.png"},{"image":"https://icons.biorender.com/w75xh75/5fe1ff5f76b8e70028333844/il-17rc-02.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5fe1ff5f76b8e70028333844/il-17rc-02.png"},{"image":"https://icons.biorender.com/w75xh75/5fe1ff5f76b8e70028333843/il-17rc-02.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5fe1ff5f76b8e70028333843/il-17rc-02.png"},{"image":"https://icons.biorender.com/w75xh75/5fe1ff5f76b8e70028333842/il-17rc-02.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5fe1ff5f76b8e70028333842/il-17rc-02.png"},{"image":"https://icons.biorender.com/w75xh75/5fe1ff5f76b8e70028333841/il-17rc-02.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5fe1ff5f76b8e70028333841/il-17rc-02.png"},{"image":"https://icons.biorender.com/w75xh75/5fe1ff5f76b8e70028333840/il-17rc-02.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5fe1ff5f76b8e70028333840/il-17rc-02.png"},{"image":"https://icons.biorender.com/w75xh75/5fe1ff5f76b8e7002833383f/il-17rc-02.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5fe1ff5f76b8e7002833383f/il-17rc-02.png"},{"image":"https://icons.biorender.com/w75xh75/5fe1ff5f76b8e7002833383e/il-17rc-02.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5fe1ff5f76b8e7002833383e/il-17rc-02.png"},{"image":"https://icons.biorender.com/w75xh75/5fe1ff5f76b8e7002833383d/il-17rc-02.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5fe1ff5f76b8e7002833383d/il-17rc-02.png"},{"image":"https://icons.biorender.com/w75xh75/5fe1ff5f76b8e7002833383c/il-17rc-02.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5fe1ff5f76b8e7002833383c/il-17rc-02.png"},{"image":"https://icons.biorender.com/w75xh75/5fe1ff5f76b8e7002833383b/il-17rc-02.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5fe1ff5f76b8e7002833383b/il-17rc-02.png"}]
Keywords
IL-17RC,IL-17RA,Interleukin 17 receptor C,IL17RC,IL17-RL,IL17RL,CANDF9,glycoprotein,cytokine,proinflammatory,multimeric,FN domain,SEFIR domain,IL-17RC